key: cord-0774094-ukosdnsa authors: Magoon, Sandeep; Bichu, Prasad; Malhotra, Varun; Alhashimi, Fatema; Hu, Yanglin; Khanna, Siddharth; Berhanu, Kabaye title: COVID-19–Related Glomerulopathy: A Report of 2 Cases of Collapsing Focal Segmental Glomerulosclerosis date: 2020-06-07 journal: Kidney Med DOI: 10.1016/j.xkme.2020.05.004 sha: 83172c2aaa4684c5a9dbeb42192cf17f57208e0c doc_id: 774094 cord_uid: ukosdnsa Coronavirus disease 19 (COVID-19), an infectious disease caused by the SARS-CoV-2 virus, has been associated with acute kidney injury (AKI), presumably due to acute tubular injury. However, this does not explain the sometimes severe proteinuria and hematuria often observed. We present 2 African American patients with glomerulopathy demonstrated by kidney biopsy in the setting of AKI and COVID-19 infection. Kidney biopsies showed collapsing variant of focal segmental glomerulosclerosis (FSGS) in addition to acute tubular injury. Both patients were homozygous for APOL1. COVID-19 infection likely caused the interferon surge as a second hit causing podocyte injury leading to collapsing FSGS. APOL1 testing should be strongly considered in African American patients with nephrotic range proteinuria. More data from future kidney biopsies will further elucidate the pathology of kidney injury and glomerular involvement from COVID-19 infections. Over the last 5 months, coronavirus disease 19 , an infectious disease caused by the SARS-CoV-2 virus, has been spreading across the globe with total number of cases exceeding 5 million and number of deaths over 300,000 and counting. The United States is currently the epicenter of COVID-19. The interaction between SARS viruses and angiotensin-converting enzyme 2 (ACE 2) has been proposed as the potential factor in their infectivity; consequently, the lungs are the most common organs involved due to the abundance of ACE 2. Involvement of other organs is not uncommon and acute kidney injury (AKI) was initially described in 3-9% of patients. . Further reports suggested kidney involvement in approximately 15% of patients and proteinuria and hematuria have been observed in 44% and 26% of patients respectively 1 . Acute tubular injury was presumed to be the most common cause of AKI, but it did not explain proteinuria, sometimes severe, and hematuria, making a case for kidney biopsy to understand the underlying etiology, whenever feasible. Studies have also shown that baseline chronic kidney disease or AKI are associated with increased mortality 1 . We present 2 patients with kidney biopsy-demonstrated glomerulopathy as a cause of AKI during COVID-19 infection. A 28-year-old African American woman with history of asthma presented to the emergency department reporting 5 days of fever, fatigue, cough, and shortness of breath. Physical examination was remarkable for temperature of 103.9° F, heart rate of 99 beats/minute, respiratory rate of 22 breaths/minute, lung auscultation with generalized wheezing, and right infra-axillary and basal crepitations. Lab results are detailed in tables 1 and 2. She had normal creatinine (0.9 mg/dl) on admission and urinalysis had significant proteinuria which was new compared to last available urinalysis from 2017. Spot urine protein to creatinine ratio was 2 g/g. Creatinine increased to 6.5 mg/dl over 4 days. Chest x-ray showed mild linear densities at the right mid and lower lung zones. Kidney ultrasound showed enlarged kidneys with maintained corticomedullary differentiation. Serological work-up including ANA and ANCA antibodies was normal. HIV and hepatitis B and C serologies were also negative. Complements were normal. She also had worsening hypoxia but did not require ventilation and was managed supportively. Dialysis was required for 34 days until kidney function improved; as of the publication of this report, the serum creatinine had not returned to baseline. APOL1 genotyping was homozygous for G1 risk allele. Other COVID symptoms have resolved. A 56-year-old African American man with history of longstanding uncontrolled hypertension, CKD stage 3 with baseline creatinine of 2 mg/dl, and recent travel to New York 2 weeks previously presented to the emergency department with fever, chills, and dry cough for 7 days along with nausea, vomiting and diarrhea for 2 days. Patient was tachycardic to a heart rate of 114 beats/minute, tachypneic with respiratory rate of 24 breaths/minute and was febrile with temperature of 100.3° F. Physical exam was remarkable for left more than right bi-basal crepitations on chest auscultation. Lab results including urinalysis are outlined in tables 3 and 4. Spot urine protein to creatinine ratio was more than 21 g/g (urine protein >2500 mg/dL and urine creatinine 118 mg/dL). Chest x-ray on admission showed hazy, patchy opacity at the peripheral left mid to lower lung field. Kidney ultrasound revealed normal size kidneys with some loss of corticomedullary differentiation. Patient developed hypoxia with worsening lung infiltrates bilaterally on chest x-ray. COVID 19 RT-PCR assay was positive. Creatinine progressively increased (3.17 to 7.72 mg/dL) and on day 5 hemodialysis was initiated for oliguric AKI and uremia. ANA, ANCA, complement levels, HIV, hepatitis B and C were negative as was work up for monoclonal gammopathy/myeloma. Kidney biopsy was performed for severe AKI with nephrotic range proteinuria. He was treated empirically with antibiotics and oxygen requirement Dialysis was required for 23 days until kidney function improved; as of the publication of this report, the serum creatinine has not returned to baseline. APOL1 genotyping on the plasma was heterozygous for G1 and G2 allele. Other COVID-19 symptoms have resolved. The exact mechanism of kidney involvement by COVID-19 infection has not been fully elucidated yet, but more data has been emerging. Possible etiologies considered are tubular injury due to cytokine storm, direct cytopathic effect and immune Both patients had collapsing FSGS in addition to tubular injury suggesting injury to the podocytes. Both our patients were African American. Viral particles were not seen in the biopsy of either patient, and hence direct cytopathic effect was not considered to be the mechanism of kidney injury, although viral level below the detection threshold cannot be excluded. In-situ hybridization was not done. It is also possible that that collapsing glomerulopathy is a bystander effect of virus driven inflammatory response or due to circulating viral gene products. testing should be strongly considered in African American patients with nephrotic range proteinuria. More data from future kidney biopsies will further elucidate the pathology of kidney injury and glomerular involvement from COVID-19 infections. As we make our way through this pandemic and hopefully out of it, the data from such kidney biopsies may help us to understand the disease process better, identify potential risk factors, and intervene early to improve outcomes. Kidney disease is associated with in-hospital death of patients with COVID-19 Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China Online ahead of print Acute Kidney Injury Due to Collapsing Glomerulopathy Following COVID-19 Infection Online ahead of print Renin-angiotensin-aldosterone system inhibitors in patients with COVID-19 Authors' Full Names and Academic Degrees: Sandeep Magoon, MD 1,2 , Prasad Bichu,